Stay updated with breaking news from Rauld Santos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alirocumab every 2 or 4 weeks significantly reduced LDL-C in pediatric patients with inadequately controlled heterozygous familial hypercholesterolemia.
A healthy lifestyle was associated with reduced risk for CVD among adults with familial hypercholesterolemia regardless of their familial hypercholesterolemia mutation status, researchers reported.“DNA is not destiny; it is not deterministic for familial hypercholesterolemia (FH),” Hayato Tada, MD, PhD, assistant professor in the department of cardiovascular medicine at Kanazawa
One expert emphasized, however, that those with high LDL cholesterol must be treated given the lifetime risk of ASCVD.